-
Topics in Evaluating the Cost-Effectiveness of Gene Therapies
May 29, 2019, 13:00 PM -
Is the FDA's New Guidance a Watershed Moment for Real-world Evidence?
May 1, 2019, 13:04 PM -
An Introduction to Pharmacovigilance
Apr 17, 2019, 10:17 AM -
MCDA - How to Guide Through the Application of Different Methods for Assessment and Prioritization of Rare Disease Health Technologies
Apr 4, 2019, 09:02 AM -
The Use of MCDA for HTA Agencies – Options, Limitations and the Way Forward
Apr 3, 2019, 09:00 AM -
Virtualizing Long-Term Follow-Up Studies for Gene Therapy Products
Mar 27, 2019, 08:50 AM -
Using RWE to Improve Healthcare Decision-making in Asia Pacific
Mar 25, 2019, 09:00 AM -
Top 10 Trends in Health Economics and Outcomes Research - 2019
Mar 22, 2019, 09:00 AM -
ISPOR Scientific Webinar Part 4: Novel Approaches To Value Assessment, BEYOND the Cost-Effectiveness Framework
Mar 6, 2019, 15:06 PM -
ISPOR Scientific Summit Webinars Part 3: Novel Approaches To Value Assessment, Within the Cost-Effectiveness Framework
Feb 28, 2019, 14:58 PM -
ISPOR Preference SIG Focus, Student Member Involvement, Working Group and Future Initiatives
Feb 25, 2019, 10:05 AM -
ISPOR Scientific Summit Webinars Part 2: Current Value Frameworks – What’s New?
Feb 22, 2019, 14:50 PM -
ISPOR Summit Seminar Webinars Part 1: Increasing the Relevance and Quality of Health Care Value Assessment
Feb 13, 2019, 14:46 PM -
PROs in Clinical Drug Development
Feb 12, 2019, 16:51 PM -
Statistical Learning: What is it? How does it relate to machine learning and AI? and How is it applied in healthcare?
Jan 30, 2019, 16:41 PM -
Prove it with PROs
Jan 24, 2019, 11:35 AM -
Why It's Time to Rethink the ICER
Jan 23, 2019, 11:18 AM -
Multi-site Outcomes Research in Precision Oncology
Dec 21, 2018, 14:35 PM -
Mapping to Estimate Health-State Utility from Non-Preference-Based Outcome Measures
Nov 27, 2018, 10:44 AM -
Constrained Optimization Methods in Health Services Research
Oct 30, 2018, 17:18 PM